Combination of MIG (CXCL9) chemokine gene therapy with low-dose cisplatin improves therapeutic efficacy against murine carcinoma

Antiangiogenic therapy of experimental cancer does not induce acquired drug resistance

Thomas Boehm, Judah Folkman, Timothy Browder et al. · Nature · 1997 · 1.7K citations

Medicine, Oncology, Pharmacology +16

Antiangiogenic scheduling of chemotherapy improves efficacy against experimental drug-resistant cancer.

Timothy M. Browder, Catherine Butterfield, Birgit M. Kräling et al. · PubMed · 2000 · 1.6K citations

Medicine, Oncology, Pharmacology +16

The Functional Role of the ELR Motif in CXC Chemokine-mediated Angiogenesis

Robert M. Strieter, Peter J. Polverini, Steven L. Kunkel et al. · Journal of Biological Chemistry · 1995 · 1.2K citations · Full text

Life Sciences, Immunology, Cell Signaling +10

Chemokine receptor specific for IP10 and mig: structure, function, and expression in activated T-lymphocytes.

Marcel Loetscher, Basil O. Gerber, Pius Loetscher et al. · The Journal of Experimental Medicine · 1996 · 1.2K citations · Full text

Life Sciences, Immunology, Molecular Biology +16

Continuous low-dose therapy with vinblastine and VEGF receptor-2 antibody induces sustained tumor regression without overt toxicity

Giannoula Klement, Sylvain Baruchel, Janusz Rak et al. · Journal of Clinical Investigation · 2000 · 1.2K citations · Full text

Medicine, Oncology, Pharmacology +11